Monro Inc/ US6102361010 /
29/05/2024 22:00:00 | Chg. -1.2200 | Volume | Bid22:07:01 | Demandez à22:07:01 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
22.5200USD | -5.14% | 1.07 Mio. Chiffrre d'affaires: 17.05 Mio. |
9.0200Bid taille: 200 | 30.4500Ask la taille: 200 | 673.72 Mio.USD | 4.97% | 18.77 |
GlobeNewswire
23:03
Kessler Topaz Meltzer & Check, LLP Reminds Inari Medical, Inc. Investors of Important Deadline in Se...
GlobeNewswire
23:01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agrify Corp...
Newsfile Corp
23:01
IAMGOLD annonce les résultats de l'assemblée générale et extraordinaire annuelle des actionnaires
GlobeNewswire
23:00
Lilium Announces Successful Arrangement of $114 Million Capital Raise With Participation From Strate...
GlobeNewswire
22:56
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, I...
GlobeNewswire
22:46
Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the ...
GlobeNewswire
22:45
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:43
Li Auto Inc. (LI) Investors: July 9, 2024 Filing Deadline in Securities Class Action - Contact Kessl...
GlobeNewswire
22:30
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire
22:30
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinica...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page